RecruitingNot ApplicableNCT06766058

Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.

Sponsor

National Cancer Centre, Singapore

Enrollment

300 participants

Start Date

Oct 22, 2024

Study Type

INTERVENTIONAL

Conditions

Breast Cancer

Summary

ASTER is a multi-part study that aims to prospectively establish evidence for the implementation of aromatherapy as complementary therapy within cancer care in the Singapore context. ASTER 2 study evaluates how extracts from Asian aromatic plants with familiar aromas introduced as inhalation therapy can alleviate distress in breast cancer patients scheduled to undergo radiotherapy (RT).

Eligibility

Sex: FEMALEMin Age: 21 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is examining whether aromatherapy — inhaling essential oils — can help reduce anxiety, fear, and emotional distress in breast cancer patients who are about to receive radiation therapy for the first time. Participants will inhale a scent before each radiation session. **You may be eligible if...** - You are 21 years or older - You have been diagnosed with breast cancer (any stage) - You are scheduled to begin your first course of radiation therapy - You are able to give informed consent **You may NOT be eligible if...** - You have a known allergy or sensitivity to essential oils or fragrances - You have airway sensitivity (e.g., asthma triggered by smells or fumes) - You are already taking anxiety medication (like benzodiazepines) before radiotherapy - You are pregnant, breastfeeding, or planning to conceive during the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.